Latham Advises BioMed Realty Trust in $8B Acquisition by Blackstone

 

California-based BioMed Realty Trust, Inc. (NYSE: BMR) has announced that it has entered into a definitive agreement with affiliates of Blackstone Real Estate Partners VIII, under which Blackstone will acquire all outstanding shares of common stock of BioMed Realty for $23.75 per share in an all-cash transaction valued at $8 billion, as detailed in the press release below issued by BioMed Realty‎.  Completion of the transaction, which is currently expected to occur in the first quarter of 2016, is contingent upon customary closing conditions, including the approval of BioMed Realty's stockholders, who will vote on the transaction at a special meeting on a date to be announced.

Latham & Watkins represents BioMed Realty Trust in the transaction with a corporate deal team led from the firm's San Diego office by partner Craig Garner, counsel Ann Buckingham and associates Kevin Reyes and Jeffrey Woodley. Advice was also provided on tax matters by Century City partner Pardis Zomorodi with New York associate Katherine Baldwin; on benefits and compensation matters by Los Angeles partner David Taub with San Diego counsel  Holly Bauer and Los Angeles associate Jack Stratton; on finance and real estate matters by San Diego partner Steve Levine with San Diego associate Jenna Woods; and on environmental matters by Orange County partner Christopher Norton.